NUPCO inks preliminary agreement to localize insulin industry in Saudi Arabia

29/10/2023 Argaam
The signing of the agreement

The signing of the agreement

National Unified Procurement Co. (NUPCO) signed today, Oct. 29, a preliminary agreement with Sudair Pharmaceutical Co. and Sanofi, to localize the insulin industry in the Kingdom.

 

The agreement was signed during the Global Health Exhibition held in Riyadh, in partnership with the Local Content & Government Procurement Authority and the Government Expenditure & Projects Efficiency Authority, to activate the contracting method for the localization of the industry and transfer of knowledge.

 

Minister of Industry and Mineral Resources Bandar AlKhorayef said the ministry aims to localize 80-90% of the Kingdom’s insulin needs, stressing the ministry’s keenness to attract qualitative investments to the pharmaceutical and healthcare sector and export to foreign markets.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.